Cigna modified MM 0099 for preterm labor and premature rupture of membranes testing, effective September 26, 2025. Here's what changes for billing teams.
Cigna Healthcare updated its coverage policy for tests evaluating preterm labor (PTL), premature rupture of membranes (PROM), and risk of preterm delivery (PTD). Under MM 0099 Cigna system, 12 codes across CPT and HCPCS are now explicitly classified — most of them landing in "Not Medically Necessary" or "Experimental/Investigational/Unproven" categories. If your practice or lab bills any of CPT 0247U, 82677, 83516–83520, 84112, 84702, 84703, 86140, 87799, or HCPCS S3652 for these indications, this policy directly affects your reimbursement.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Tests for the Evaluation of Preterm Labor and Premature Rupture of Membranes |
| Policy Code | MM 0099 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | High |
| Specialties Affected | OB/GYN, Maternal-Fetal Medicine, Clinical Laboratory, High-Risk Obstetrics |
| Key Action | Audit active charge capture for all 12 affected codes and flag claims for Cigna patients before September 26, 2025 |
Cigna Preterm Labor Testing Coverage Criteria and Medical Necessity Requirements 2025
The core issue with the Cigna preterm labor coverage policy is that it takes an aggressive stance: most of the commonly billed biomarker tests for preterm labor risk are not covered. That's not a subtle shift. It means claims going out with these codes against Cigna plans will face denial unless something very specific in the policy permits coverage.
The policy addresses three distinct clinical scenarios. Those are evaluation of active preterm labor, diagnosis of premature rupture of membranes, and prediction of preterm delivery risk. Each scenario has its own set of applicable codes — and almost all of them fall outside covered territory.
The medical necessity bar here is high, and based on the policy's structure, Cigna is drawing a hard line between tests used for active clinical management and tests used for risk stratification or prediction. The latter group gets the worst treatment. Tests that predict future preterm delivery risk — rather than confirm an active clinical event — are the primary targets of the "Not Medically Necessary" label.
There is no prior authorization pathway listed in this policy for the excluded codes. That matters because it means there's no mechanism to seek coverage for these tests through prior auth, even in high-risk pregnancies. If your billing team has been submitting prior authorization requests hoping to unlock coverage for any of the biomarker codes listed here, that strategy won't work under this policy. Talk to your compliance officer about how your practice documents medical necessity for these tests before the effective date of September 26, 2025.
Cigna Preterm Labor and PROM Testing Exclusions and Non-Covered Indications
This is where the policy does the most damage to revenue cycle teams. Cigna splits the 12 affected codes into two buckets: "Not Medically Necessary" and "Experimental/Investigational/Unproven." Both lead to the same outcome — a claim denial — but the reasoning is different, and that matters for appeals.
Experimental/Investigational/Unproven means Cigna does not believe sufficient clinical evidence supports the test for this indication. These designations are harder to appeal because you're arguing against the payer's clinical evidence assessment, not just their medical necessity determination. The codes in this bucket include:
| # | Excluded Procedure |
|---|---|
| 1 | CPT 0247U — This is the PreTRM test, a proprietary obstetrics panel measuring insulin-like growth factor–binding protein 4 (IBP4) and sex hormone–binding globulin (SHBG). Cigna considers it experimental for preterm birth risk assessment. |
| 2 | CPT 82677 — Estriol testing, used historically to assess preterm delivery risk. Cigna labels this experimental for these indications. |
| 3 | CPT 84112 — This code covers evaluation of cervicovaginal fluid for specific amniotic fluid proteins, such as placental alpha microglobulin-1 (PAMG-1). The AmniSure test is the most recognized test in this category. Cigna considers it experimental for PROM evaluation. |
| 4 | HCPCS S3652 — Saliva hormone level testing to assess preterm labor risk. Experimental/investigational designation. |
The "Not Medically Necessary" bucket covers the broader biomarker immunoassay codes and a few other tests. These codes are not inherently experimental — they're standard lab codes used across many indications. Cigna's position is that using them specifically for preterm labor and PROM biomarker testing is not medically necessary. The affected codes here are:
| # | Excluded Procedure |
|---|---|
| 1 | CPT 83516, 83518, 83519, 83520 — Immunoassay panels for various analytes, qualitative and quantitative. When used to report biomarker testing in the preterm labor context, Cigna denies these as not medically necessary. |
| 2 | CPT 84702 and 84703 — Quantitative and qualitative chorionic gonadotropin (hCG) testing. Same situation — standard codes, but the specific indication of preterm labor biomarker testing is the problem. |
| 3 | CPT 86140 — C-reactive protein. Not medically necessary when used as a preterm labor biomarker. |
| 4 | CPT 87799 — Infectious agent nucleic acid detection, not otherwise specified. Not medically necessary for this indication. |
The real issue here is that CPT 83516 through 83520 are widely used codes that appear across dozens of lab billing scenarios. If your lab bills these codes with diagnosis codes pointing toward preterm labor evaluation, you now have a direct denial pathway under this Cigna policy. Audit your diagnosis code pairings immediately.
Coverage Indications at a Glance
| Indication | Coverage Status | Relevant Codes | Notes |
|---|---|---|---|
| Preterm birth risk assessment using IBP4/SHBG panel (PreTRM) | Experimental/Investigational/Unproven | CPT 0247U | No appeal pathway through prior auth |
| PROM evaluation using amniotic fluid protein (PAMG-1) | Experimental/Investigational/Unproven | CPT 84112 | Covers AmniSure and similar tests |
| Estriol testing for preterm delivery risk | Experimental/Investigational/Unproven | CPT 82677 | Historical test, still denied |
| Saliva hormone testing for preterm labor risk | Experimental/Investigational/Unproven | HCPCS S3652 | Niche test, outright experimental |
| Immunoassay biomarker panels (qualitative) for preterm labor | Not Medically Necessary | CPT 83516, 83518 | Review diagnosis code pairings |
| Immunoassay biomarker panels (quantitative) for preterm labor | Not Medically Necessary | CPT 83519, 83520 | Review diagnosis code pairings |
| hCG testing as preterm labor biomarker | Not Medically Necessary | CPT 84702, 84703 | Applies only to this indication |
| CRP testing as preterm labor biomarker | Not Medically Necessary | CPT 86140 | Standard code, indication-specific denial |
| Nucleic acid detection for preterm labor biomarker use | Not Medically Necessary | CPT 87799 | Indication-specific denial |
Cigna Preterm Labor Testing Billing Guidelines and Action Items 2025
The billing guidelines here aren't complicated — but the follow-through requires discipline across your charge capture, coding, and denial management workflows. Start now. September 26, 2025 is the effective date.
| # | Action Item |
|---|---|
| 1 | Pull a 90-day lookback on all 12 affected codes billed to Cigna. Identify every claim that used CPT 0247U, 82677, 83516, 83518, 83519, 83520, 84112, 84702, 84703, 86140, 87799, or HCPCS S3652 with an obstetric or preterm labor diagnosis. This tells you your current exposure and gives you a baseline for what's about to start denying. |
| 2 | Update your charge capture and order sets before September 26, 2025. If your EHR or lab order interface auto-populates these codes for preterm labor workups, flag them. Your coders need to know that Cigna will deny these before submitting — not after. Build in a payer-specific edit for Cigna claims using these codes. |
| 3 | Separate your denial appeal strategies by bucket. Claims denied as "Not Medically Necessary" have a different appeal pathway than those denied as "Experimental/Investigational." For the NMN bucket (CPT 83516–83520, 84702, 84703, 86140, 87799), strong clinical documentation may support an appeal. For the experimental bucket (CPT 0247U, 82677, 84112, S3652), appeals face a higher bar — Cigna's position is evidence-based, not just administrative. Consult your billing consultant before building your appeal templates. |
| 4 | Review patient financial liability disclosures for affected tests. If your practice performs tests in the experimental/investigational category and patients have Cigna coverage, you need a clear ABN-equivalent process. Patients should know before the test that Cigna considers it experimental and that they may owe the full cost. This is a compliance and patient experience issue, not just a billing issue. Loop in your compliance officer if you haven't addressed this. |
| 5 | Audit diagnosis code pairings for CPT 83516–83520 specifically. These are high-volume immunoassay codes used across many indications. The problem isn't the codes themselves — it's the diagnosis codes attached to them. If your preterm labor evaluation claims are landing on these codes with ICD-10 codes in the O60 (preterm labor) or O42 (PROM) range, those pairings will now trigger denial under this Cigna preterm labor billing policy. Work with your coding team to identify whether any of these tests are legitimately being billed for a different indication that Cigna does cover. If so, documentation must clearly support that separate indication. |
| 6 | Do not expect prior authorization to unlock coverage here. There's no PA pathway listed in this policy for any of the non-covered or experimental codes. If your team has been requesting prior auth for tests like CPT 0247U or 84112 under Cigna, stop. Approval of a prior auth for an excluded service doesn't guarantee reimbursement — and in this case, the policy doesn't even offer that pathway. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Preterm Labor Testing Under MM 0099
Experimental / Investigational / Unproven Codes
| Code | Type | Description | Cigna Status |
|---|---|---|---|
| 0247U | CPT | Obstetrics (preterm birth), insulin-like growth factor–binding protein 4 (IBP4), sex hormone–binding globulin (SHBG) | Experimental/Investigational/Unproven |
| 82677 | CPT | Estriol | Experimental/Investigational/Unproven |
| 84112 | CPT | Evaluation of cervicovaginal fluid for specific amniotic fluid protein(s) (e.g., placental alpha microglobulin-1) | Experimental/Investigational/Unproven |
| S3652 | HCPCS | Saliva test, hormone level; to assess preterm labor risk | Experimental/Investigational/Unproven |
Not Medically Necessary Codes
| Code | Type | Description | Cigna Status |
|---|---|---|---|
| 83516 | CPT | Immunoassay for analyte other than infectious agent antibody or antigen; qualitative | Not Medically Necessary for preterm labor biomarker use |
| 83518 | CPT | Immunoassay for analyte other than infectious agent antibody or antigen; qualitative | Not Medically Necessary for preterm labor biomarker use |
| 83519 | CPT | Immunoassay for analyte other than infectious agent antibody or antigen; quantitative | Not Medically Necessary for preterm labor biomarker use |
| 83520 | CPT | Immunoassay for analyte other than infectious agent antibody or antigen; quantitative | Not Medically Necessary for preterm labor biomarker use |
| 84702 | CPT | Gonadotropin, chorionic (hCG); quantitative | Not Medically Necessary for preterm labor biomarker use |
| 84703 | CPT | Gonadotropin, chorionic (hCG); qualitative | Not Medically Necessary for preterm labor biomarker use |
| 86140 | CPT | C-reactive protein | Not Medically Necessary for preterm labor biomarker use |
| 87799 | CPT | Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; quantification, each organism | Not Medically Necessary for preterm labor biomarker use |
Note on ICD-10 codes: The MM 0099 policy data does not list specific ICD-10-CM codes. However, claims pairing the codes above with diagnosis codes in the O60 (preterm labor) and O42 (premature rupture of membranes) ranges are the primary risk area under this policy. Review those pairings with your coding team.
Get the Full Picture for CPT 82677
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.